Premium
P2‐107: Depression treatment and risk of dementia: A new user cohort study
Author(s) -
Whitmer Rachel A.,
Quesenberry Charles P.,
Liu Jennifer Y.,
Yaffe Kristine
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.645
Subject(s) - dementia , medicine , cohort , depression (economics) , pharmacotherapy , hazard ratio , medical prescription , psychiatry , proportional hazards model , cohort study , neurology , pediatrics , disease , economics , macroeconomics , confidence interval , pharmacology
mean 25.17, median 26, SD 3.34; Alzheimer’s Disease (n1⁄4223)mean 16.33, median 16, SD 6.43; Cerebral Degeneration (n1⁄4236)mean 20.47, median 21, SD 6.10; Memory Loss (n1⁄4162)mean 25.24, median 27, SD 5.2; Dementia (n1⁄4 86)mean 15.12, median 14, SD 5.23.Conclusions:ABCs scores vary appropriately by diagnosis and resembleMMSE scoring distributions. This instrument provides a non-proprietary cognitive screening evaluation to be used by physicians to detect cognitive deficits in the clinical setting and to aid in defining the degree, quality and progression of impairment.